|Title||NMIHBA results from hypomorphic PRUNE1 variants that lack short-chain exopolyphosphatase activity.|
|Publication Type||Journal Article|
|Year of Publication||2020|
|Authors||Nistala, H, Dronzek, J, Gonzaga-Jauregui, C, Chim, SMan, Rajamani, S, Nuwayhid, S, Delgado, D, Burke, E, Karaca, E, Franklin, MC, Sarangapani, P, Podgorski, M, Tang, Y, Dominguez, MG, Withers, M, Deckelbaum, RA, Scheonherr, CJ, Gahl, WA, Malicdan, MC, Zambrowicz, B, Gale, NW, Gibbs, RA, Chung, WK, Lupski, JR, Economides, AN|
|Journal||Hum Mol Genet|
|Date Published||2020 Oct 26|
Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies (NMIHBA) is an autosomal recessive neurodevelopmental and neurodegenerative disorder characterized by global developmental delay and severe intellectual disability. Microcephaly, progressive cortical atrophy, cerebellar hypoplasia and delayed myelination are neurological hallmarks in affected individuals. NMIHBA is caused by biallelic variants in PRUNE1 encoding prune exopolyphosphatase 1. We provide in-depth clinical description of two affected siblings harboring compound heterozygous variant alleles, c.383G > A (p.Arg128Gln), c.520G > T (p.Gly174*) in PRUNE1. To gain insights into disease biology, we biochemically characterized missense variants within the conserved N-terminal aspartic acid-histidine-histidine (DHH) motif and provide evidence that they result in the destabilization of protein structure and/or loss of exopolyphosphatase activity. Genetic ablation of Prune1 results in midgestational lethality in mice, associated with perturbations to embryonic growth and vascular development. Our findings suggest that NMIHBA results from hypomorphic variant alleles in humans and underscore the potential key role of PRUNE1 exopolyphoshatase activity in neurodevelopment.
|Alternate Journal||Hum Mol Genet|